Predictors of clinical outcome in advanced heart failure patients on continuous intravenous milrinone therapy

ASAIO Journal

Volumn 52, Issue 6, 2006, Pages 677-681

  Bhat, Geetha ^a,b  

^a JEWISH HOSPITAL   (United States)

^b LifeLink Transplant Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG THERAPY; HEMODYNAMICS; MEDICAL APPLICATIONS; MEDICAL PROBLEMS; PATIENT MONITORING;

CARDIAC TRANSPLANT (CT); HEART FAILURE; HOME-BASED MILRINONE THERAPY (HMT);

CARDIOVASCULAR SYSTEM;

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; ISOSORBIDE DINITRATE; MILRINONE; SPIRONOLACTONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART ASSIST DEVICE; HEART ATRIUM FLUTTER; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HOME CARE; HUMAN; HYPOTENSION; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; OXYGEN SATURATION; PATIENT SELECTION; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; AGE FACTORS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CARDIOTONIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HOME CARE SERVICES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MILRINONE; OUTPATIENTS; OXYGEN; PHOSPHODIESTERASE INHIBITORS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY WEDGE PRESSURE; TREATMENT OUTCOME;

EID: 33751216759     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mat.0000233884.12218.5a     Document Type: Article

References (15)

1. Colucci WS: Myocardial and vascular actions of milrinone. Eur Heart J 10(Suppl C):32-38, 1989.
2. Hatzizacharias A, Makris T, Krespi P, et al: Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure. Am Heart J 138: 241-246, 1999.
3. Felker GM, Benza RL, Chandler AB, et al: Heart failure etiology and response to milrinone in decompensated heart failure: Results from the OPTIME-CHF study. J Am Coll Cardiol 41: 997-1003, 2003.
4. Packer M, Carver JR, Rodeheffer RJ, et al: Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 325: 1468-1475, 2003.
5. Cuffe MS, Califf RM, Adams KF, et al: Short-term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial. JAMA 281: 1541-1547, 2002.
6. Smits JM, Deng MC, Hummel M, et al: Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group. A prognostic model for predicting waiting-list mortality for a total national cohort of adult heart-transplant candidates. Transplantation 76: 1185-1189, 2003.
7. Brozena SC, Twomey C, Goldberg LR, et al: A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home. J Heart Lung Transplant 23: 1082-1086, 2004.
8. Upadya S, Lee FA, Saldarriaga C, et al: Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure. J Heart Lung Transplant 23: 466-472, 2004.
9. Young JB, Moen EK: Outpatient parenteral inotropic therapy for advanced heart failure. J Heart Lung Transplant 19: S49-57, 2000.
10. Matsuda H, Matsumiya G: Current status of left ventricular assist devices: the role in bridge to heart transplantation and future perspectives. J Artif Organs 6: 157-161, 2003.
11. Mehra MR, Ventura HO, Kapoor C, et al: Safety and clinical utility of long-term intravenous milrinone in advanced heart failure. Am J Cardiol 80: 61-64, 1997.
12. Harjai KJ, Mehra MR, Ventura HO, et al: Home inotropic therapy in advanced heart failure: Cost analysis and clinical outcomes. Chest 112: 1298-1303, 1997.
13. Canver CC, Chanda J: Milrinone for long-term pharmacologic support of the status 1 heart transplant candidates. Ann Thorac Surg 69: 1823-1826, 2000.
14. Young JB: New therapeutic choices in the management of acute congestive heart failure. Rev Cardiovasc Med 2: S19-24, 2001.
15. Lang CC, Hankins S, Hauff H, et al: Morbidity and mortality of UNOS status 1B cardiac transplant candidates at home. J Heart Lung Transplant 22: 419-426, 2003.